ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/17 | 2,668 | 2,677 | 2,646 | 2,660 | -7 | -0.3% | 146,600 |
2023/04/14 | 2,679 | 2,687 | 2,664 | 2,667 | +10 | +0.4% | 145,300 |
2023/04/13 | 2,650 | 2,660 | 2,641 | 2,657 | +8 | +0.3% | 85,200 |
2023/04/12 | 2,649 | 2,666 | 2,646 | 2,649 | +5 | +0.2% | 88,500 |
2023/04/11 | 2,643 | 2,661 | 2,643 | 2,644 | +7 | +0.3% | 133,800 |
2023/04/10 | 2,635 | 2,647 | 2,624 | 2,637 | +11 | +0.4% | 107,300 |
2023/04/07 | 2,658 | 2,666 | 2,626 | 2,626 | -21 | -0.8% | 120,500 |
2023/04/06 | 2,630 | 2,655 | 2,621 | 2,647 | +11 | +0.4% | 202,400 |
2023/04/05 | 2,680 | 2,685 | 2,636 | 2,636 | -57 | -2.1% | 139,700 |
2023/04/04 | 2,683 | 2,697 | 2,664 | 2,693 | +21 | +0.8% | 210,200 |
2023/04/03 | 2,643 | 2,679 | 2,638 | 2,672 | +42 | +1.6% | 306,900 |
2023/03/31 | 2,626 | 2,644 | 2,620 | 2,630 | +5 | +0.2% | 214,100 |
2023/03/30 | 2,633 | 2,633 | 2,610 | 2,625 | -23 | -0.9% | 231,800 |
2023/03/29 | 2,620 | 2,650 | 2,612 | 2,648 | +35 | +1.3% | 268,100 |
2023/03/28 | 2,620 | 2,627 | 2,604 | 2,613 | -6 | -0.2% | 146,200 |
2023/03/27 | 2,619 | 2,625 | 2,604 | 2,619 | +14 | +0.5% | 158,800 |
2023/03/24 | 2,575 | 2,609 | 2,567 | 2,605 | +25 | +1% | 133,900 |
2023/03/23 | 2,577 | 2,584 | 2,556 | 2,580 | -8 | -0.3% | 176,200 |
2023/03/22 | 2,596 | 2,614 | 2,577 | 2,588 | +10 | +0.4% | 251,500 |
2023/03/20 | 2,599 | 2,606 | 2,577 | 2,578 | -36 | -1.4% | 169,600 |
2023/03/17 | 2,628 | 2,637 | 2,614 | 2,614 | -11 | -0.4% | 221,800 |
2023/03/16 | 2,597 | 2,631 | 2,593 | 2,625 | +14 | +0.5% | 218,100 |
2023/03/15 | 2,600 | 2,623 | 2,595 | 2,611 | +16 | +0.6% | 150,100 |
2023/03/14 | 2,597 | 2,611 | 2,583 | 2,595 | -25 | -1% | 294,300 |
2023/03/13 | 2,616 | 2,623 | 2,605 | 2,620 | -28 | -1.1% | 202,000 |
2023/03/10 | 2,644 | 2,665 | 2,644 | 2,648 | -27 | -1% | 201,000 |
2023/03/09 | 2,642 | 2,675 | 2,639 | 2,675 | +43 | +1.6% | 216,100 |
2023/03/08 | 2,625 | 2,636 | 2,612 | 2,632 | +5 | +0.2% | 258,800 |
2023/03/07 | 2,602 | 2,627 | 2,601 | 2,627 | +25 | +1% | 275,800 |
2023/03/06 | 2,601 | 2,607 | 2,587 | 2,602 | +11 | +0.4% | 289,000 |
2023/03/03 | 2,570 | 2,594 | 2,569 | 2,591 | +22 | +0.9% | 235,100 |
2023/03/02 | 2,560 | 2,586 | 2,553 | 2,569 | +23 | +0.9% | 203,300 |
2023/03/01 | 2,564 | 2,564 | 2,536 | 2,546 | -45 | -1.7% | 633,200 |
2023/02/28 | 2,605 | 2,611 | 2,590 | 2,591 | -16 | -0.6% | 328,800 |
2023/02/27 | 2,607 | 2,611 | 2,590 | 2,607 | -1 | ±0% | 315,800 |
2023/02/24 | 2,610 | 2,611 | 2,591 | 2,608 | -3 | -0.1% | 277,700 |
2023/02/22 | 2,635 | 2,639 | 2,610 | 2,611 | -32 | -1.2% | 201,200 |
2023/02/21 | 2,630 | 2,644 | 2,620 | 2,643 | +13 | +0.5% | 177,300 |
2023/02/20 | 2,633 | 2,646 | 2,622 | 2,630 | +15 | +0.6% | 187,100 |
2023/02/17 | 2,601 | 2,619 | 2,596 | 2,615 | +6 | +0.2% | 266,600 |
2023/02/16 | 2,615 | 2,619 | 2,599 | 2,609 | +2 | +0.1% | 271,600 |
2023/02/15 | 2,620 | 2,621 | 2,601 | 2,607 | -13 | -0.5% | 199,400 |
2023/02/14 | 2,619 | 2,627 | 2,610 | 2,620 | +13 | +0.5% | 113,200 |
2023/02/13 | 2,615 | 2,615 | 2,601 | 2,607 | -7 | -0.3% | 204,100 |
2023/02/10 | 2,623 | 2,627 | 2,610 | 2,614 | -16 | -0.6% | 242,200 |
2023/02/09 | 2,632 | 2,645 | 2,622 | 2,630 | -22 | -0.8% | 234,800 |
2023/02/08 | 2,627 | 2,663 | 2,627 | 2,652 | +36 | +1.4% | 227,800 |
2023/02/07 | 2,617 | 2,632 | 2,610 | 2,616 | -10 | -0.4% | 314,000 |
2023/02/06 | 2,639 | 2,647 | 2,610 | 2,626 | -85 | -3.1% | 584,100 |
2023/02/03 | 2,724 | 2,727 | 2,701 | 2,711 | -16 | -0.6% | 166,100 |
501~
550
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム